Dr. Al-Atrash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
- Cleveland Clinic FoundationResidency, Internal Medicine, 2002 - 2005
- Texas College of Osteopathic MedicineClass of 2002
Certifications & Licensure
- FL State License 2021 - Present
- AZ State License 2023 - 2026
- TX State License 2005 - 2026
- AL State License 2023 - 2025
- GA State License 2023 - 2025
- LA State License 2023 - 2025
- MS State License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Start of enrollment: 2018 Oct 11
- 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II Start of enrollment: 2020 Sep 29
Publications & Presentations
PubMed
- 1 citationsEfficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia.Jason Yeh, Oren Pasvolsky, Rima M Saliba, Bradley Figgins, Christopher Wang
Clinical Lymphoma, Myeloma & Leukemia. 2024-11-01 - 2 citationsTargeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia.Guillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, Feiyang Ma, Irene Ganan-Gomez
Cell Reports. Medicine. 2024-06-18 - 1 citationsAzacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.Oren Pasvolsky, Rima M Saliba, Uday R Popat, Amin Alousi, Rohtesh Mehta
Clinical Lymphoma, Myeloma & Leukemia. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: